Proactive Risk Assessments Aligned with ICH Q9 and GMP Standards
Indivirtus Healthcare Services delivers strategic risk management audits to identify, assess, and mitigate risks across your pharmaceutical operations, ensuring compliance and product safety.
Risk management audits involve systematic identification, assessment, and mitigation of risks across the pharmaceutical product lifecycle, from development to distribution. Our services align with ICH Q9, WHO TRS, Schedule M, and 21 CFR Part 211 to ensure compliance and safety.
Unmanaged risks can lead to product recalls, regulatory non-compliance, or patient safety issues. Our audits proactively address risks through tools like FMEA and HACCP, ensuring robust risk control and regulatory adherence.
Indivirtus Healthcare Services conducts thorough risk assessments to safeguard your operations. We provide actionable insights and documentation to mitigate risks, enhance compliance, and support your global market objectives.
At Indivirtus Healthcare Services, our risk management audits are designed to proactively identify and mitigate risks across your pharmaceutical operations. Our certified experts follow ICH Q9 principles, employing tools like FMEA (Failure Modes and Effects Analysis) and HACCP (Hazard Analysis and Critical Control Points) to assess risks at every stage—from process development to distribution. We conduct detailed process risk reviews and develop comprehensive risk control documentation tailored to your needs.
Our collaborative approach ensures we understand your unique challenges, delivering customized solutions that align with GMP and regulatory standards. We empower your team with clear, actionable strategies to maintain product quality and compliance.
ICH Q9 Risk Assessment Report: A comprehensive report detailing identified risks and mitigation strategies.
FMEA / HACCP Audit Summary: A summary of findings from Failure Modes and Effects Analysis and Hazard Analysis audits.
Risk Control Plan: A tailored plan to address and mitigate identified risks.
Process Risk Evaluation Matrix: A structured matrix to evaluate and prioritize process risks.
Our risk management audits adhere to stringent regulatory frameworks, including ICH Q9, WHO TRS, Schedule M, and 21 CFR Part 211. This ensures your operations are audit-ready and compliant with global standards, minimizing regulatory risks and supporting market access.
By aligning with these guidelines, we provide robust documentation and risk control measures that withstand scrutiny from regulatory authorities, ensuring your pharmaceutical operations meet the highest quality and compliance standards.
Our risk management services are critical during product development, process validation, or facility expansions, ensuring risks are identified and mitigated early. They are also essential for ongoing operations to maintain compliance and address emerging risks in manufacturing or distribution.
Whether you’re launching a new product, scaling operations, or preparing for a regulatory inspection, our audits provide the tools and insights needed to ensure safety, quality, and compliance across your pharmaceutical lifecycle.
Indivirtus Healthcare Services brings unmatched expertise to risk management, with a team of certified toxicologists and global regulatory specialists. Our scientifically defensible audits deliver rapid, actionable results, ensuring minimal disruption to your operations. We prioritize confidentiality and adhere to industry best practices, safeguarding your sensitive data.
Partner with us to proactively manage risks, enhance compliance, and build a resilient pharmaceutical operation that meets global standards.
The goal is to identify, assess, and control risks throughout the product lifecycle, ensuring compliance with ICH Q9 and other GMP standards.
FMEA identifies failure points in processes, evaluates their impact, and prioritizes them for corrective action to prevent quality deviations.
HACCP audits focus on identifying critical control points, monitoring procedures, and corrective actions in production and packaging processes.
ICH Q9 provides a structured approach to risk management, helping companies make science-based, risk-based decisions in compliance environments.
Outputs include risk assessment matrices, mitigation plans, updated SOPs, and documentation of acceptance criteria and residual risk levels.
A risk management audit identifies, assesses, and mitigates risks across the pharmaceutical product lifecycle, using tools like FMEA and HACCP, and aligning with ICH Q9, WHO TRS, Schedule M, and 21 CFR Part 211.
ICH Q9 provides a structured approach to quality risk management, ensuring proactive risk identification and mitigation, which is critical for regulatory compliance and patient safety.
You’ll receive an ICH Q9 Risk Assessment Report, FMEA/HACCP Audit Summary, Risk Control Plan, and Process Risk Evaluation Matrix to address and prioritize risks.
We align our audits with ICH Q9, WHO TRS, Schedule M, and 21 CFR Part 211, ensuring your risk management processes are compliant and audit-ready for global markets.
Risk management audits are ideal during product development, process validation, facility expansions, or routine operations to proactively address risks and ensure compliance.